Effective communication between your diabetes or weight management specialist and our eye care team is essential for safe treatment
Association between glucagon-like peptide-1 receptor agonists exposure and intraocular pressure change: GLP-1 receptor agonists and intraocular pressure change
Other diagnoses and medications: Depending on what other diseases or conditions you have been diagnosed with, and what medications you are taking, your dose may need to be adjusted
In a statement Monday, Jared Shapiro, a Lilly spokesperson, said all doses of Mounjaro and Zepbound are available, warning that its important that patients not be exposed to the risks in taking untested, unapproved knockoffs. Nothing changes the fact that, as FDA has recognized, Mounjaro and Zepbound are available and the shortage remains resolved, Shapiro said
Genetic insight guides realistic transition planning